Jafron BiomedicalLtd Past Earnings Performance
Past criteria checks 2/6
Jafron BiomedicalLtd has been growing earnings at an average annual rate of 2.7%, while the Medical Equipment industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 11.2% per year. Jafron BiomedicalLtd's return on equity is 15.9%, and it has net margins of 25.1%.
Key information
2.7%
Earnings growth rate
2.5%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 11.2% |
| Return on equity | 15.9% |
| Net Margin | 25.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40
May 28
A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)
May 24Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge
May 08Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture
May 02Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital
Apr 13Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?
Mar 22Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce
Mar 04Revenue & Expenses Breakdown
How Jafron BiomedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,094 | 525 | 798 | 246 |
| 31 Dec 23 | 1,922 | 436 | 784 | 245 |
| 30 Sep 23 | 1,952 | 440 | 826 | 268 |
| 30 Jun 23 | 1,949 | 419 | 855 | 269 |
| 31 Mar 23 | 2,367 | 751 | 862 | 267 |
| 01 Jan 23 | 2,491 | 890 | 837 | 254 |
| 30 Sep 22 | 2,919 | 1,207 | 843 | 240 |
| 30 Jun 22 | 3,041 | 1,325 | 839 | 222 |
| 31 Mar 22 | 2,794 | 1,249 | 750 | 194 |
| 01 Jan 22 | 2,675 | 1,197 | 736 | 174 |
| 30 Sep 21 | 2,417 | 1,111 | 665 | 129 |
| 30 Jun 21 | 2,269 | 1,055 | 634 | 101 |
| 31 Mar 21 | 2,151 | 974 | 638 | 89 |
| 31 Dec 20 | 1,951 | 875 | 588 | 81 |
| 30 Sep 20 | 1,776 | 780 | 587 | 69 |
| 30 Jun 20 | 1,643 | 706 | 557 | 69 |
| 31 Mar 20 | 1,516 | 626 | 541 | 67 |
| 31 Dec 19 | 1,432 | 571 | 539 | 68 |
| 30 Sep 19 | 1,290 | 514 | 482 | 62 |
| 30 Jun 19 | 1,219 | 498 | 447 | 56 |
| 31 Mar 19 | 1,105 | 442 | 414 | 50 |
| 31 Dec 18 | 1,017 | 402 | 388 | 46 |
| 30 Sep 18 | 925 | 387 | 338 | 41 |
| 30 Jun 18 | 846 | 345 | 304 | 47 |
| 31 Mar 18 | 777 | 315 | 290 | 36 |
| 31 Dec 17 | 718 | 284 | 277 | 27 |
| 30 Sep 17 | 662 | 266 | 246 | 17 |
| 30 Jun 17 | 612 | 251 | 240 | 0 |
| 31 Mar 17 | 566 | 215 | 225 | 0 |
| 31 Dec 16 | 544 | 202 | 220 | 0 |
| 30 Sep 16 | 537 | 204 | 215 | 0 |
| 30 Jun 16 | 547 | 209 | 217 | 0 |
| 31 Mar 16 | 532 | 210 | 208 | 0 |
| 31 Dec 15 | 509 | 200 | 194 | 0 |
| 31 Dec 14 | 371 | 160 | 139 | 0 |
| 31 Dec 13 | 304 | 127 | 109 | 0 |
Quality Earnings: 300529 has high quality earnings.
Growing Profit Margin: 300529's current net profit margins (25.1%) are lower than last year (31.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300529's earnings have grown by 2.7% per year over the past 5 years.
Accelerating Growth: 300529's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300529 had negative earnings growth (-30.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (0.09%).
Return on Equity
High ROE: 300529's Return on Equity (15.9%) is considered low.